Inactive Instrument

Insiders Trillium Therapeutics

Equities

TRIL

CA89620X5064

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

TCR2 Therapeutics Appoints Chief Business and Strategy Officer	22-01-12	MT
Trillium Therapeutics Inc. Announces Executive Changes	21-11-17	CI
Trillium Therapeutics Inc. Announces Resignation of Jan Skvarka as Chief Executive Officer	21-11-17	CI
Trillium Therapeutics Inc. Appoints Catherine Mackey as a Member of the Board	21-06-30	CI
Trillium Therapeutics Inc. Board Changes	21-04-28	CI
Trillium Therapeutics Inc. Appoints Paolo Pucci to Its Board of Directors	20-11-12	CI
Trillium Therapeutics Inc. Announces Executive Changes	20-11-02	CI
Trillium Therapeutics Inc. Announces the Formation of Scientific Advisory Board	20-11-02	CI
Trillium Therapeutics Inc. Appoints Michael Kamarck to Its Board of Directors, Effective Immediately	20-09-18	CI
Jeff Settleman Agrees to Join Trillium Therapeutics Inc.'s Scientific Advisory Board	20-09-09	CI
Trillium Therapeutics Inc. Announces the Retirement of Dr. Calvin Stiller and Dr. Michael Moore from the Board	20-07-06	CI
Trillium Therapeutics Inc. Announces Changes to its Board of Directors	20-02-07	CI
Trillium Therapeutics Inc. Names Jan Skvarka as President and Chief Executive Officer	19-09-25	CI
Trillium Therapeutics Inc. Announces Management and Board Changes; Provides Corporate Update; Opens Office in Cambridge, Massachusetts	19-04-30	CI
Trillium Therapeutics Appoints Yaping Shou, MD, PhD as Chief Medical Officer	18-06-07	CI
Trillium Appoints Dr. Henry Friesen as Director Emeritus and Retirement from the Board of Directors	18-06-05	CI
Trillium Therapeutics Inc Announces Executive Appointments	18-01-17	CI
Trillium Therapeutics Inc. Appoints Helen Tayton-Martin to its Board of Directors	17-10-11	CI
Trillium Therapeutics Inc. Appoints Eric L. Sievers as Chief Medical Officer	15-03-27	CI
Stem Cell Therapeutics Corp. has Changed its Name to Trillium Therapeutics Inc	14-05-27	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Trillium Therapeutics

Equities

TRIL

CA89620X5064

Insiders

Filters